Interference testing of HBOC-201, an oxygen based therapeutic, with Dade Behring chemistry assays performed on the Dimension® clinical chemistry system

被引：0
作者：
Rea, DM
Posey, A
Caffo, AL
机构：
[1] Dade Behring Inc, Newark, DE USA
[2] W Chester Univ, W Chester, PA 19380 USA
来源：
CLINICAL CHEMISTRY | 2005年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A49 / A50
页数：2
相关论文
共 50 条
[31]   Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring Dimension RxL clinical chemistry analyzer [J].
Terrell, AR ;
Daly, TM ;
Hock, KG ;
Kilgore, DC ;
Wei, TQ ;
Hernandez, S ;
Weibe, D ;
Fields, L ;
Shaw, LM ;
Scott, MG .
CLINICAL CHEMISTRY, 2002, 48 (07) :1059-1065
[32]   Validation of revised iron Flex® reagent and calibrator on dade behring Dimension® clinical chemistry systems [J].
Wesenberg, J. ;
Mannino, E. ;
Anderson, D. .
CLINICAL CHEMISTRY, 2007, 53 (06) :A35-A35
[33]   Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer [J].
Griffey, Megan A. ;
Hock, Karl G. ;
Kilgore, Daniel C. ;
Wei, Tie Q. ;
Duh, Show-Hong ;
Christenson, Robert ;
Scott, Mitchell G. .
CLINICA CHIMICA ACTA, 2007, 384 (1-2) :48-51
[34]   An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the dade-behring dimension RxL max clinical chemistry system [J].
Mendu, Damodara Rao ;
Chou, Peter P. ;
Soldin, Steven J. .
THERAPEUTIC DRUG MONITORING, 2007, 29 (05) :632-637
[35]   Evaluation of the Dade Behring Dimension RxL: integrated chemistry system-pediatric reference ranges [J].
Ghoshal, AK ;
Soldin, SJ .
CLINICA CHIMICA ACTA, 2003, 331 (1-2) :135-146
[36]   Development of a sandwich assay for NT-proBNP using monoclonal antibodies on the dade behring Dimension® clinical chemistry system [J].
Wei, T. ;
Janas, S. ;
Duffy, J. ;
Desai, V. ;
Sharma, M. ;
Bedzyk, W. ;
Singh, P. .
CLINICAL CHEMISTRY, 2006, 52 (06) :A140-A140
[37]   Development of a no-pretreatment immunoassay for CSA C2 monitoring on the Dade Behring Dimension® clinical chemistry system [J].
Wei, T ;
Bantum, L ;
Bolle, G .
THERAPEUTIC DRUG MONITORING, 2005, 27 (02) :212-212
[38]   Analytical and clinical performance of the NT-proBNP assay on the Dade Behring Dimension® clinical chemistry system and the Stratus® CSSTAT Fluorometric Analyzer [J].
Christenson, RH ;
Scott, MG ;
Hock, KG ;
Jones, HL ;
Figgs, TR .
CLINICAL CHEMISTRY, 2005, 51 :A19-A20
[39]   Determination of total and free plasma carnitine concentrations on the Dade Behring Dimension RxL: Integrated chemistry system [J].
Ghoshal, AK ;
Soldin, SJ .
CLINICA CHIMICA ACTA, 2005, 361 (1-2) :80-85
[40]   Development and analytical performance of an improved method for cardiac troponin-I on the Dade Behring Dimension® clinical chemistry system. [J].
Kaminski, D ;
Sivakoff, S ;
McCormack, B ;
Pierson-Perry, J .
CLINICAL CHEMISTRY, 2001, 47 (06) :A211-A212
12345